CStone Pharmaceuticals has collaborated with Bayer HealthCare to study the combination of its investigational drug CS1001 with Bayer’s regorafenib to...
Read More...
The post CStone partners with Bayer on combination therapy for cancer appeared first on Drug Development Technology.
Original Article: CStone partners with Bayer on combination therapy for cancer